ADVANCED BIOMEDICAL (ABMT)

[mlkrborn]

Law suit: $4 stock. Abiomed (ABMD) announced that a purported class action complaint was filed on November 16, The complaint claims that its and Chrmn, CEO and CFO violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 in connection with alleged disclosures related to the FDA and the marketing and labeling of Abiomed's Impella 2.5 product. The plaintiffs seek a jury trial. Co has reviewed the complaint and believes that the allegations are without merit.